#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page